List of works - Audrey GABELLE

A Complex Relationship Between Suicide, Dementia, and Amyloid: A Narrative Review.

scientific article published in June 2018

A diagnostic scale for Alzheimer's disease based on cerebrospinal fluid biomarker profiles

scientific article

A meta-analysis of human embryonic stem cells transcriptome integrated into a web-based expression atlas.

scientific article published on 4 January 2007

A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease

scientific article published on 11 March 2020

Absolute quantification of 35 plasma biomarkers in human saliva using targeted MS

scientific article published on 09 December 2015

Alzheimer's Disease: Advances in Drug Development

scientific article published on 01 January 2018

Alzheimer's disease cerebro-spinal fluid biomarkers: A clinical research tool sometimes useful in daily clinical practice of memory clinics for the diagnosis of complex cases

scientific article published on 24 November 2016

Amyloid imaging in Alzheimer's disease: a literature review.

scientific article published on July 2014

Analytical challenges related to the use of biomarker ratios for the biological diagnosis of Alzheimer's disease

scientific article

Antibody-free quantification of seven tau peptides in human CSF using targeted mass spectrometry.

scientific article

Anxiety and 10-Year Risk of Incident Dementia-An Association Shaped by Depressive Symptoms: Results of the Prospective Three-City Study.

scientific article

Are migraine and non-migrainous headache risk factors for stroke in the elderly? Findings from a 12-year cohort follow-up

scientific article

Association between serum hepcidin level and restless legs syndrome

scientific article published on 8 February 2018

Association of Long-Term Diet Quality with Hippocampal Volume: Longitudinal Cohort Study

scientific article published on 26 July 2018

Autoantibody profiling on high-density protein microarrays for biomarker discovery in the cerebrospinal fluid

scientific article published on 24 July 2008

Biomarkers of Alzheimer's disease: the present and the future.

scientific article published on 07 September 2013

Can event-related potential predict the progression of mild cognitive impairment?

scientific article published in December 2011

Can we rely only on ratios of cerebrospinal fluid biomarkers for AD biological diagnosis?

scientific article published on 15 November 2014

Central Nervous System and Peripheral Inflammatory Processes in Alzheimer's Disease: Biomarker Profiling Approach.

scientific article

Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Cerebral Amyloid Angiopathy-Related Inflammation.

scientific article

Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Isolated Supratentorial Cortical Superficial Siderosis.

scientific article published in October 2016

Cerebrospinal fluid Alzheimer biomarkers can be useful for discriminating dementia with Lewy bodies from Alzheimer's disease at the prodromal stage.

scientific article published on 10 January 2018

Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study

scientific article published on June 2015

Cerebrospinal fluid levels of orexin-A and histamine, and sleep profile within the Alzheimer process.

scientific article

Cognitive Event-Related Potential, an Early Diagnosis Biomarker in Frail Elderly Subjects: The ERP-MAPT-PLUS Ancillary Study.

scientific article published on 29 March 2017

Decreased sAβPPβ, Aβ38, and Aβ40 cerebrospinal fluid levels in frontotemporal dementia.

scientific article published in January 2011

Demographic, neurological and behavioural characteristics and brain perfusion SPECT in frontal variant of frontotemporal dementia.

scientific article published in November 2006

Development and validation of dried matrix spot sampling for the quantitative determination of amyloid β peptides in cerebrospinal fluid.

scientific article

Development of new quantitative mass spectrometry and semi-automatic isofocusing methods for the determination of Apolipoprotein E typing.

scientific article published on 18 December 2015

Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer's Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies.

scientific article

Editorial: Collaborative Efforts to Prevent Alzheimer's Disease

scientific article published in January 2017

Excessive Sleepiness and Longer Nighttime in Bed Increase the Risk of Cognitive Decline in Frail Elderly Subjects: The MAPT-Sleep Study

scientific article published on 28 September 2017

From radioimmunoassay to mass spectrometry: a new method to quantify orexin-A (hypocretin-1) in cerebrospinal fluid.

scientific article published on 11 May 2016

Generation of induced pluripotent stem cells (IRMBi001-A) from an Alzheimer's disease patient carrying a G217D mutation in the PSEN1 gene

scientific article published on 03 January 2019

HIV Neuroinfection and Alzheimer's Disease: Similarities and Potential Links?

article

How to optimize the use of biobanks from population-based cohorts in aging research.

scientific article

Hypocretin and brain β-amyloid peptide interactions in cognitive disorders and narcolepsy.

scientific article

Identification of multiple proteoforms biomarkers on clinical samples by routine Top-Down approaches.

scientific article

Impact of cerebro-spinal fluid biomarkers of Alzheimer's disease in clinical practice: a multicentric study.

scientific article

Impact of harmonization of collection tubes on Alzheimer's disease diagnosis.

scientific article published on 23 October 2013

Influence of activity space on the association between neighborhood characteristics and dementia risk: results from the 3-City study cohort

scientific article published on 07 January 2019

Intake of Meat, Fish, Fruits, and Vegetables and Long-Term Risk of Dementia and Alzheimer's Disease

scientific article published on 01 January 2019

Neurodegenerative dementia and parkinsonism.

scientific article published on January 2010

Palmomental Reflex a Relevant Sign in Early Alzheimer's Disease Diagnosis?

scientific article published on 26 November 2015

Parkinson's disease dementia and Lewy body dementia

scholarly article by Florence Portet et al published 1 December 2006 in Psychologie & neuropsychiatrie du vieillissement

Pathogenic p62/SQSTM1 mutations impair energy metabolism through limitation of mitochondrial substrates.

scientific article

Plasma β-amyloid 40 levels are positively associated with mortality risks in the elderly.

scientific article published on 9 July 2014

Predicting dementia using socio-demographic characteristics and the Free and Cued Selective Reminding Test in the general population.

scientific article published on 23 March 2017

Primary Progressive Aphasia in the Network of French Alzheimer Plan Memory Centers

scientific article published on 02 September 2016

Prion replication occurs in endogenous adult neural stem cells and alters their neuronal fate: involvement of endogenous neural stem cells in prion diseases

scientific article

Quantification of hepcidin-25 in human cerebrospinal fluid using LC-MS/MS.

scientific article published on 20 January 2017

Quantitative detection of amyloid-β peptides by mass spectrometry: state of the art and clinical applications

scientific article

Relevance of Aβ42/40 Ratio for Detection of Alzheimer Disease Pathology in Clinical Routine: The PLMR Scale.

scientific article

Risk of Alzheimer's Disease Biological Misdiagnosis Linked to Cerebrospinal Collection Tubes

scientific article published on 01 January 2012

SILK studies - capturing the turnover of proteins linked to neurodegenerative diseases

scientific article published on 20 June 2019

Sensory-motor neuropathy: a slow and misleading case of leprosy

scientific article published on 12 May 2008

Sex-specific association between neighborhood characteristics and dementia: The Three-City cohort

scientific article

Somatostatin and Neuropeptide Y in Cerebrospinal Fluid: Correlations With Amyloid Peptides Aβ and Tau Proteins in Elderly Patients With Mild Cognitive Impairment

scientific article published on 01 October 2018

Stable Isotope Labeling by Amino acid in Vivo (SILAV): a new method to explore protein metabolism.

scientific article

Systemic delivery of siRNA down regulates brain prion protein and ameliorates neuropathology in prion disorder.

scientific article

Tau Protein Quantification in Human Cerebrospinal Fluid by Targeted Mass Spectrometry at High Sequence Coverage Provides Insights into Its Primary Structure Heterogeneity.

scientific article published on 7 January 2016

The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases

scientific article published on 30 January 2019

Towards a routine application of Top-Down approaches for label-free discovery workflows

scientific article

[CSF biomarkers: proteomics investigations and clinical applications in neurodegenerative disorders]

scientific article published on 07 July 2008

List of works by Audrey GABELLE

A Complex Relationship Between Suicide, Dementia, and Amyloid: A Narrative Review.

A diagnostic scale for Alzheimer's disease based on cerebrospinal fluid biomarker profiles

A meta-analysis of human embryonic stem cells transcriptome integrated into a web-based expression atlas.

A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease

Absolute quantification of 35 plasma biomarkers in human saliva using targeted MS

Alzheimer's Disease: Advances in Drug Development

Alzheimer's disease cerebro-spinal fluid biomarkers: A clinical research tool sometimes useful in daily clinical practice of memory clinics for the diagnosis of complex cases

Amyloid imaging in Alzheimer's disease: a literature review.

Analytical challenges related to the use of biomarker ratios for the biological diagnosis of Alzheimer's disease

Antibody-free quantification of seven tau peptides in human CSF using targeted mass spectrometry.

Anxiety and 10-Year Risk of Incident Dementia-An Association Shaped by Depressive Symptoms: Results of the Prospective Three-City Study.

Are migraine and non-migrainous headache risk factors for stroke in the elderly? Findings from a 12-year cohort follow-up

Association between serum hepcidin level and restless legs syndrome

Association of Long-Term Diet Quality with Hippocampal Volume: Longitudinal Cohort Study

Autoantibody profiling on high-density protein microarrays for biomarker discovery in the cerebrospinal fluid

Biomarkers of Alzheimer's disease: the present and the future.

Can event-related potential predict the progression of mild cognitive impairment?

Can we rely only on ratios of cerebrospinal fluid biomarkers for AD biological diagnosis?

Central Nervous System and Peripheral Inflammatory Processes in Alzheimer's Disease: Biomarker Profiling Approach.

Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Cerebral Amyloid Angiopathy-Related Inflammation.

Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Isolated Supratentorial Cortical Superficial Siderosis.

Cerebrospinal fluid Alzheimer biomarkers can be useful for discriminating dementia with Lewy bodies from Alzheimer's disease at the prodromal stage.

Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study

Cerebrospinal fluid levels of orexin-A and histamine, and sleep profile within the Alzheimer process.

Cognitive Event-Related Potential, an Early Diagnosis Biomarker in Frail Elderly Subjects: The ERP-MAPT-PLUS Ancillary Study.

Decreased sAβPPβ, Aβ38, and Aβ40 cerebrospinal fluid levels in frontotemporal dementia.

Demographic, neurological and behavioural characteristics and brain perfusion SPECT in frontal variant of frontotemporal dementia.

Development and validation of dried matrix spot sampling for the quantitative determination of amyloid β peptides in cerebrospinal fluid.

Development of new quantitative mass spectrometry and semi-automatic isofocusing methods for the determination of Apolipoprotein E typing.

Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer's Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies.

Editorial: Collaborative Efforts to Prevent Alzheimer's Disease

Excessive Sleepiness and Longer Nighttime in Bed Increase the Risk of Cognitive Decline in Frail Elderly Subjects: The MAPT-Sleep Study

From radioimmunoassay to mass spectrometry: a new method to quantify orexin-A (hypocretin-1) in cerebrospinal fluid.

Generation of induced pluripotent stem cells (IRMBi001-A) from an Alzheimer's disease patient carrying a G217D mutation in the PSEN1 gene

HIV Neuroinfection and Alzheimer's Disease: Similarities and Potential Links?

How to optimize the use of biobanks from population-based cohorts in aging research.

Hypocretin and brain β-amyloid peptide interactions in cognitive disorders and narcolepsy.

Identification of multiple proteoforms biomarkers on clinical samples by routine Top-Down approaches.

Impact of cerebro-spinal fluid biomarkers of Alzheimer's disease in clinical practice: a multicentric study.

Impact of harmonization of collection tubes on Alzheimer's disease diagnosis.

Influence of activity space on the association between neighborhood characteristics and dementia risk: results from the 3-City study cohort

Intake of Meat, Fish, Fruits, and Vegetables and Long-Term Risk of Dementia and Alzheimer's Disease

Neurodegenerative dementia and parkinsonism.

Palmomental Reflex a Relevant Sign in Early Alzheimer's Disease Diagnosis?

Parkinson's disease dementia and Lewy body dementia

Pathogenic p62/SQSTM1 mutations impair energy metabolism through limitation of mitochondrial substrates.

Plasma β-amyloid 40 levels are positively associated with mortality risks in the elderly.

Predicting dementia using socio-demographic characteristics and the Free and Cued Selective Reminding Test in the general population.

Primary Progressive Aphasia in the Network of French Alzheimer Plan Memory Centers

Prion replication occurs in endogenous adult neural stem cells and alters their neuronal fate: involvement of endogenous neural stem cells in prion diseases

Quantification of hepcidin-25 in human cerebrospinal fluid using LC-MS/MS.

Quantitative detection of amyloid-β peptides by mass spectrometry: state of the art and clinical applications

Relevance of Aβ42/40 Ratio for Detection of Alzheimer Disease Pathology in Clinical Routine: The PLMR Scale.

Risk of Alzheimer's Disease Biological Misdiagnosis Linked to Cerebrospinal Collection Tubes

SILK studies - capturing the turnover of proteins linked to neurodegenerative diseases

Sensory-motor neuropathy: a slow and misleading case of leprosy

Sex-specific association between neighborhood characteristics and dementia: The Three-City cohort

Somatostatin and Neuropeptide Y in Cerebrospinal Fluid: Correlations With Amyloid Peptides Aβ and Tau Proteins in Elderly Patients With Mild Cognitive Impairment

Stable Isotope Labeling by Amino acid in Vivo (SILAV): a new method to explore protein metabolism.

Systemic delivery of siRNA down regulates brain prion protein and ameliorates neuropathology in prion disorder.

Tau Protein Quantification in Human Cerebrospinal Fluid by Targeted Mass Spectrometry at High Sequence Coverage Provides Insights into Its Primary Structure Heterogeneity.

The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases

Towards a routine application of Top-Down approaches for label-free discovery workflows

[CSF biomarkers: proteomics investigations and clinical applications in neurodegenerative disorders]